Latest Nanoform News & Updates

See the latest news and media coverage for Nanoform. We track all announcements, press releases, and industry mentions in real time, all in one place.

Nanoform

Nanotechnology drug particle engineering services provider

nanoform.com

Headquarters: Helsinki, Finland
Founded year: 2015
Company type: Public company
Number of employees: 125–200

Last updated Today

Latest news about Nanoform

In short: Nanoform reported record Q1 2026 revenue and gross margins while announcing its first biologics exclusivity deal with a U.S. biopharma company.

Company announcements

May 29 Nanoform

Nanoform issues stock options to key individuals

The options are free of charge with a subscription price of EUR 1.70 per share, totaling up to 420,000 shares.

May 19 Nanoform

Nanoform reports record Q1 revenue and gross margin

Revenue grew 45% to EUR 1.3m, gross margin 94%, and first biologics exclusivity deal signed.

May 12 Nanoform

Nanoform signs first exclusivity agreement for subcutaneous delivery

The agreement with a U.S. biopharma company includes a $1M upfront fee and potential milestones.

April 21 Nanoform

Nanoform holds Annual General Meeting

Approves financial statements, no dividend, re-elects board members, authorizes share repurchases and issuances. 35 shareholders represent 41.5% of shares.

Media coverage

May 31 Kauppalehti

The 'Pharma Tesla' of the Helsinki Stock Exchange got a blockbuster deal - CEO: Huge news

Medical technology company Nanoform signed an agreement with a US company. The good news is overshadowed by the sufficiency of funding and the delay in the company's drug marketing authorization application. "You don't have to wait long," the CFO says ...

May 27 Yahoo Finance

Nanoform Finland PLC (FRA:4YL) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ...

Nanoform Finland PLC (FRA:4YL) achieves record first-quarter revenue and gross margin, signs a significant exclusivity deal, and progresses towards long-term business targets.

May 19 FinanzNachrichten

Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology

EEST Record first quarter revenue, income and gross margin. Revenue grew by 45%, gross margin reached 94% and operating costs fell by 31...

May 12 Arvopaperi

Nanoform continues rocketing, Kamux sinks on the Helsinki Stock Exchange

In the Helsinki Stock Exchange, Tuesday afternoon progressed in a slightly upward atmosphere. Earnings season. Clear reactions have been seen in the shares of today's earnings reporters. PICTURE: KIMMO HAAPALA Today13:47 Laura Lähdevuori He...

Never miss news about Nanoform

Track Nanoform and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.